ash2018 - Cleveland Clinic

Tag debug info: client: {"assets":{},"datasets":{},"live":{},"projects":{},"users":{},"observable":{"assets":{},"datasets":{},"live":{},"projects":{},"users":{}}}
Now: 1774288173447
Cache Key: cqdTagPageBySlug:ash2018
fetchCache[cqdTagPageBySlug:ash2018].expirationTime: falsey
fetchCache[cqdTagPageBySlug:ash2018]. seconds remaining: falsey
All fetchCache expiration times:
-- Key: cqdNotFoundPage, seconds remaining: -4707465
-- Key: cqdTagPageBySlug:digestive-disease-week-2021, seconds remaining: -44811903
-- Key: cqdPostsByTag:cqd-migrated-tag-23392,1,10, seconds remaining: -44811816
-- Key: cqdTagPageBySlug:cannabis, seconds remaining: -41437107
-- Key: cqdPostsByTag:cqd-migrated-tag-20214,1,10, seconds remaining: -41437018
-- Key: cqdTagPageBySlug:vulvovaginal-atrophy, seconds remaining: -28439775
-- Key: cqdPostsByTag:cqd-migrated-tag-21024,1,10, seconds remaining: -28439611
-- Key: cqdTagPageBySlug:canagliflozin, seconds remaining: -16117612
-- Key: cqdPostsByTag:cqd-migrated-tag-20758,1,10, seconds remaining: -16117519
-- Key: cqdTagPageBySlug:transcatheter-tricuspid-valve-replacement-ttvr, seconds remaining: -8618372
-- Key: cqdPostsByTag:cqd-migrated-tag-8096,1,10, seconds remaining: -8618288
-- Key: cqdTagPageBySlug:brain-cancer, seconds remaining: -6579844
-- Key: cqdPostsByTag:cqd-migrated-tag-19063,1,10, seconds remaining: -6579759
-- Key: cqdTagPageBySlug:esophagogastroduodenoscopy, seconds remaining: -6569906
-- Key: cqdPostsByTag:cqd-migrated-tag-20634,1,10, seconds remaining: -6569824
-- Key: cqdTagPageBySlug:ventricular-tachycardia-vt, seconds remaining: -4707465
-- Key: cqdPostsByTag:cqd-migrated-tag-20883,1,10, seconds remaining: -4707382
conditions:
-- false,
-- NA,
-- NA,
-- NA
-- false
Cache miss for key cqdTagPageBySlug:ash2018 - retrieving from Sanity
CCCache.dataFetchCount: 130
Cache cleanup seconds remaining: 90000

Tag: ash2018

Oral Anticoagulants Show Benefit for Cancer Patients at High Risk of Venous Thromboembolism

Molecular Data Helps Better Predict Survival for Patients with Myelodysplastic Syndrome

More Evidence that CAR T-Cell Therapy Works for Many Patients with Large B-Cell Lymphoma

The Next Step in Immunotherapy for Myeloid Hematologic Malignancies

Good Response Rate for New Anemia Drug in Patients with Myelodysplastic Syndromes

Blinatumomab Trial: 66 Percent of Patients Achieve Remission from Acute Lymphoblastic Leukemia